FY15 Labor, HHS and Education Appropriation related to preparedness for pandemic influenza, HIV/AIDS programs, hepatitis screening, care and treatment, and access to breast cancer treatment.
Legislation on public health preparedness and response related to pandemic influenza. Influenza Pandemic Preparedness federal, state and local levels. Legislation on screening, care and treatment for hepatitis.
Duration: January 1, 2008
to
July 31, 2014
General Issues: Budget/Appropriations , Health Issues
Spending: about $1,230,000 (But it's complicated. Here's why.)
It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.
Agencies lobbied since 2008: House of Representatives, U.S. Senate
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
3rd Quarter, 2014
WINNING STRATEGIES WASHINGTON terminated an engagement in which they represented GENENTECH, INC. (FORMERLY KNOWN AS HOFFMAN-LA ROCHE, INC) on Oct. 20, 2014.
Original Filing: 300686345.xml
Lobbying Issues
FY15 Labor, HHS and Education Appropriation related to preparedness for pandemic influenza, HIV/AIDS programs, hepatitis screening, care and treatment, and access to breast cancer treatment.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Legislation on public health preparedness and response related to pandemic influenza. Influenza Pandemic Preparedness federal, state and local levels. Legislation on screening, care and treatment for hepatitis.
Agencies Lobbied
U.S. House of Representatives
2nd Quarter, 2014
In Q2, WINNING STRATEGIES WASHINGTON lobbied for GENENTECH, INC. (FORMERLY KNOWN AS HOFFMAN-LA ROCHE, INC) , earning $30,000. The report was filed on July 21, 2014.
Original Filing: 300665811.xml
Lobbying Issues
FY15 Labor, HHS and Education Appropriation related to preparedness for pandemic influenza, HIV/AIDS programs, hepatitis screening, care and treatment, and access to breast cancer treatment.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Legislation on public health preparedness and response related to pandemic influenza. Influenza Pandemic Preparedness federal, state and local levels. Legislation on screening, care and treatment for hepatitis.
Agencies Lobbied
U.S. House of Representatives
1st Quarter, 2014
In Q1, WINNING STRATEGIES WASHINGTON lobbied for GENENTECH, INC. (FORMERLY KNOWN AS HOFFMAN-LA ROCHE, INC) , earning $30,000. The report was filed on April 21, 2014.
Original Filing: 300647796.xml
Lobbying Issues
FY14 and FY15 Labor, HHS and Education Appropriation related to preparedness for pandemic influenza, HIV/AIDS programs, hepatitis screening, care and treatment, and access to breast cancer treatment.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Legislation on public health preparedness and response related to pandemic influenza. Influenza Pandemic Preparedness federal, state and local levels. Legislation on screening, care and treatment for hepatitis.
Agencies Lobbied
U.S. House of Representatives
4th Quarter, 2013
In Q4, WINNING STRATEGIES WASHINGTON lobbied for GENENTECH, INC. (FORMERLY KNOWN AS HOFFMAN-LA ROCHE, INC) , earning $30,000. The report was filed on Jan. 21, 2014.
Original Filing: 300623110.xml
Lobbying Issues
FY14 Labor, HHS and Education Appropriation related to preparedness for pandemic influenza, HIV/AIDS programs, hepatitis screening, care and treatment, and access to breast cancer treatment.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Legislation on public health preparedness and response related to pandemic influenza. Influenza Pandemic Preparedness federal, state and local levels. Legislation on screening, care and treatment for hepatitis.
Agencies Lobbied
U.S. House of Representatives
3rd Quarter, 2013
In Q3, WINNING STRATEGIES WASHINGTON lobbied for GENENTECH, INC. (FORMERLY KNOWN AS HOFFMAN-LA ROCHE, INC) , earning $30,000. The report was filed on Oct. 17, 2013.
Original Filing: 300597181.xml
Lobbying Issues
FY14 Labor, HHS and Education Appropriation related to preparedness for pandemic influenza, HIV/AIDS programs, hepatitis screening, care and treatment, and access to breast cancer treatment.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Legislation on public health preparedness and response related to pandemic influenza. Influenza Pandemic Preparedness federal, state and local levels. Legislation on screening, care and treatment for hepatitis.
Agencies Lobbied
U.S. House of Representatives
2nd Quarter, 2013
In Q2, WINNING STRATEGIES WASHINGTON lobbied for GENENTECH, INC. (FORMERLY KNOWN AS HOFFMAN-LA ROCHE, INC) , earning $30,000. The report was filed on July 22, 2013.
Original Filing: 300584909.xml
Lobbying Issues
FY14 Labor, HHS and Education Appropriation related to preparedness for pandemic influenza, HIV/AIDS programs, hepatitis screening, care and treatment, and access to breast cancer treatment.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Legislation on public health preparedness and response related to pandemic influenza. Influenza Pandemic Preparedness federal, state and local levels. Legislation on screening, care and treatment for hepatitis.
Agencies Lobbied
U.S. House of Representatives
1st Quarter, 2013
In Q1, WINNING STRATEGIES WASHINGTON lobbied for GENENTECH, INC. (FORMERLY KNOWN AS HOFFMAN-LA ROCHE, INC) , earning $30,000. The report was filed on April 22, 2013.
Original Filing: 300560756.xml
Lobbying Issues
FY14 Labor, HHS and Education Appropriation related to preparedness for pandemic influenza, HIV/AIDS programs, hepatitis screening, care and treatment, and access to breast cancer treatment.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Legislation on public health preparedness and response related to pandemic influenza. Influenza Pandemic Preparedness federal, state and local levels. Legislation on screening, care and treatment for hepatitis.
Agencies Lobbied
U.S. House of Representatives
4th Quarter, 2012
In Q4, WINNING STRATEGIES WASHINGTON lobbied for GENENTECH, INC. (FORMERLY KNOWN AS HOFFMAN-LA ROCHE, INC) , earning $30,000. The report was filed on Jan. 22, 2013.
Original Filing: 300539444.xml
Lobbying Issues
FY13 Labor, HHS and Education Appropriation related to preparedness for pandemic influenza, HIV/AIDS programs, hepatitis screening, care and treatment, and access to breast cancer treatment.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Legislation on public health preparedness and response related to pandemic influenza. Influenza Pandemic Preparedness federal, state and local levels. Legislation on screening, care and treatment for hepatitis.
Agencies Lobbied
U.S. House of Representatives
3rd Quarter, 2012
In Q3, WINNING STRATEGIES WASHINGTON lobbied for GENENTECH, INC. (FORMERLY KNOWN AS HOFFMAN-LA ROCHE, INC) , earning $30,000. The report was filed on Oct. 22, 2012.
Original Filing: 300520443.xml
Lobbying Issues
FY13 Labor, HHS and Education Appropriation related to preparedness for pandemic influenza, HIV/AIDS programs, hepatitis screening, care and treatment, and access to breast cancer treatment.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Legislation on public health preparedness and response related to pandemic influenza. Influenza Pandemic Preparedness federal, state and local levels. Legislation on screening, care and treatment for hepatitis.
Agencies Lobbied
U.S. House of Representatives
2nd Quarter, 2012
In Q2, WINNING STRATEGIES WASHINGTON lobbied for GENENTECH, INC. (FORMERLY KNOWN AS HOFFMAN-LA ROCHE, INC) , earning $30,000. The report was filed on July 20, 2012.
Original Filing: 300495165.xml
Lobbying Issues
FY13 Labor, HHS and Education Appropriation related to preparedness for pandemic influenza, HIV/AIDS programs, hepatitis screening, care and treatment, and access to breast cancer treatment.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Legislation on public health preparedness and response related to pandemic influenza. Influenza Pandemic Preparedness federal, state and local levels. Legislation on screening, care and treatment for hepatitis.
Agencies Lobbied
U.S. House of Representatives
1st Quarter, 2012
In Q1, WINNING STRATEGIES WASHINGTON lobbied for GENENTECH, INC. (FORMERLY KNOWN AS HOFFMAN-LA ROCHE, INC) , earning $30,000. The report was filed on April 19, 2012.
Original Filing: 300466741.xml
Lobbying Issues
FY13 Labor, HHS and Education Appropriation related to preparedness for pandemic influenza, HIV/AIDS programs, hepatitis screening, care and treatment, and access to breast cancer treatment.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Legislation on public health preparedness and response related to pandemic influenza. Influenza Pandemic Preparedness federal, state and local levels. Legislation on screening, care and treatment for hepatitis.
Agencies Lobbied
U.S. House of Representatives
4th Quarter, 2011
In Q4, WINNING STRATEGIES WASHINGTON lobbied for GENENTECH, INC. (FORMERLY KNOWN AS HOFFMAN-LA ROCHE, INC) , earning $50,000. The report was filed on Jan. 20, 2012.
Original Filing: 300449854.xml
Lobbying Issues
FY12 Labor, HHS and Education Appropriation related to preparedness for pandemic influenza, HIV/AIDS programs, hepatitis screening, care and treatment, and access to breast cancer treatment.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Legislation on public health preparedness and response related to pandemic influenza. Influenza Pandemic Preparedness federal, state and local levels. Legislation on screening, care and treatment for hepatitis.
Agencies Lobbied
U.S. House of Representatives
3rd Quarter, 2011
In Q3, WINNING STRATEGIES WASHINGTON lobbied for GENENTECH, INC. (FORMERLY KNOWN AS HOFFMAN-LA ROCHE, INC) , earning $50,000. The report was filed on Oct. 18, 2011.
Original Filing: 300418493.xml
Lobbying Issues
FY12 Labor, HHS and Education Appropriation related to preparedness for pandemic influenza, HIV/AIDS programs, hepatitis screening, care and treatment, and access to breast cancer treatment.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Legislation on public health preparedness and response related to pandemic influenza. Influenza Pandemic Preparedness federal, state and local levels. Legislation on screening, care and treatment for hepatitis.
Agencies Lobbied
U.S. House of Representatives
2nd Quarter, 2011
In Q2, WINNING STRATEGIES WASHINGTON lobbied for GENENTECH, INC. (FORMERLY KNOWN AS HOFFMAN-LA ROCHE, INC) , earning $50,000. The report was filed on July 19, 2011.
Original Filing: 300398400.xml
Lobbying Issues
FY11, FY12 Labor, HHS and Education Appropriation related to preparedness for pandemic influenza, HIV/AIDS programs, hepatitis screening, care and treatment, and access to breast cancer treatment.
Implementation of H.R. 2346, S. 1054 FY09 Supplemental Appropriations related to preparedness for pandemic influenza.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Legislation on public health preparedness and response related to pandemic influenza. Influenza Pandemic Preparedness federal, state and local levels. Legislation on screening, care and treatment for hepatitis.
Agencies Lobbied
U.S. House of Representatives
1st Quarter, 2011
In Q1, WINNING STRATEGIES WASHINGTON lobbied for GENENTECH, INC. (FORMERLY KNOWN AS HOFFMAN-LA ROCHE, INC) , earning $50,000. The report was filed on April 19, 2011.
Original Filing: 300371602.xml
Lobbying Issues
FY11, FY12 Labor, HHS and Education Appropriation related to preparedness for pandemic influenza, HIV/AIDS programs and HCV screening, care and treatment.
Implementation of H.R. 2346, S. 1054 FY09 Supplemental Appropriations related to preparedness for pandemic influenza.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Legislation on public health preparedness and response related to pandemic influenza.
Influenza Pandemic Preparedness federal, state and local levels.
Agencies Lobbied
U.S. House of Representatives
4th Quarter, 2010
In Q4, WINNING STRATEGIES WASHINGTON lobbied for GENENTECH, INC. (FORMERLY KNOWN AS HOFFMAN-LA ROCHE, INC) , earning $50,000. The report was filed on Jan. 20, 2011.
Original Filing: 300350001.xml
Lobbying Issues
FY11 Labor, HHS and Education Appropriation related to preparedness for pandemic influenza, HIV/AIDS programs and HCV screening, care and treatment.
Implementation of H.R. 2346, S. 1054 FY09 Supplemental Appropriations related to preparedness for pandemic influenza.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Legislation on public health preparedness and response related to pandemic influenza.
Influenza Pandemic Preparedness federal, state and local levels.
H.R. 3974, Viral Hepatitis and Liver Cancer Control and Prevention act of 2009
H.R. 3590 Patient Protection and Affordable Care Act-FTC issueRyan White CARE Act reauthorization
Agencies Lobbied
U.S. House of Representatives
3rd Quarter, 2010
In Q3, WINNING STRATEGIES WASHINGTON lobbied for GENENTECH, INC. (FORMERLY KNOWN AS HOFFMAN-LA ROCHE, INC) , earning $50,000. The report was filed on Oct. 19, 2010.
Original Filing: 300320724.xml
Lobbying Issues
FY11 Labor, HHS and Education Appropriation related to preparedness for pandemic influenza, HIV/AIDS programs and HCV screening, care and treatment.
Implementation of H.R. 2346, S. 1054 FY09 Supplemental Appropriations related to preparedness for pandemic influenza.
FY11 State Foreign Operations Appropriations related to USAID and funding for Pandemic Influenza
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Legislation on public health preparedness and response related to pandemic influenza.
Influenza Pandemic Preparedness federal, state and local levels.
H.R. 3974, Viral Hepatitis and Liver Cancer Control and Prevention act of 2009
H.R. 3590 Patient Protection and Affordable Care Act-FTC issue
Ryan White CARE Act reauthorization
Agencies Lobbied
U.S. House of Representatives
2nd Quarter, 2010
In Q2, WINNING STRATEGIES WASHINGTON lobbied for GENENTECH, INC. (FORMERLY KNOWN AS HOFFMAN-LA ROCHE, INC) , earning $60,000. The report was filed on July 20, 2010.
Original Filing: 300296279.xml
Lobbying Issues
FY11 Labor, HHS and Education Appropriation related to preparedness for pandemic influenza, HIV/AIDS programs and HCV screening, care and treatment.
Implementation of H.R. 2346, S. 1054 FY09 Supplemental Appropriations related to preparedness for pandemic influenza.
FY11 State Foreign Operations Appropriations related to USAID and funding for Pandemic Influenza
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Legislation on public health preparedness and response related to pandemic influenza.
Influenza Pandemic Preparedness federal, state and local levels.
H.R. 3974, Viral Hepatitis and Liver Cancer Control and Prevention act of 2009
H.R. 3590 Patient Protection and Affordable Care Act-FTC issue
Ryan White CARE Act reauthorization
Agencies Lobbied
U.S. House of Representatives
1st Quarter, 2010
In Q1, WINNING STRATEGIES WASHINGTON lobbied for GENENTECH, INC. (FORMERLY KNOWN AS HOFFMAN-LA ROCHE, INC) , earning $70,000. The report was filed on April 20, 2010.
Original Filing: 300267600.xml
Lobbying Issues
FY11 Labor, HHS and Education Appropriation related to preparedness for pandemic influenza, HIV/AIDS programs and HCV screening, care and treatment.
Implementation of H.R. 2346, S. 1054 FY09 Supplemental Appropriations related to preparedness for pandemic influenza.
FY11 State Foreign Operations Appropriations related to USAID and funding for Pandemic Influenza
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Legislation on public health preparedness and response related to pandemic influenza. S.1445 and H.R. 2552, Senate and House versions of the Hepatitis C Epidemic Control and Prevention Act.
Influenza Pandemic Preparedness federal, state and local levels.
H.R. 3974, Viral Hepatitis and Liver Cancer Control and Prevention act of 2009H.R. 3590 Patient Protection and Affordable Care Act-FTC issue
Ryan White CARE Act reauthorization
Agencies Lobbied
U.S. House of Representatives
4th Quarter, 2009
In Q4, WINNING STRATEGIES WASHINGTON lobbied for HOFFMAN-LA ROCHE, INC , earning $30,000. The report was filed on Jan. 20, 2010.
Original Filing: 300242142.xml
Lobbying Issues
H.R. 3293 FY10 Labor, HHS and Education Appropriation related to preparedness for pandemic influenza, HIV/AIDS programs and HCV screening, care and treatment.
H.R. 2346, S. 1054 FY09 Supplemental Appropriations related to preparedness for pandemic influenza.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Legislation on public health preparedness and response related to pandemic influenza. S.1445 and H.R. 2552, Senate and House versions of the Hepatitis C Epidemic Control and Prevention Act.
Influenza Pandemic Preparedness federal, state and local levels.
H.R. 3200, health care reform legislationRyan White CARE Act reauthorization
Agencies Lobbied
U.S. House of Representatives
3rd Quarter, 2009
In Q3, WINNING STRATEGIES WASHINGTON lobbied for HOFFMAN-LA ROCHE, INC , earning $80,000. The report was filed on Oct. 19, 2009.
Original Filing: 300212831.xml
Lobbying Issues
H.R. 3293 FY10 Labor, HHS and Education Appropriation related to preparedness for pandemic influenza, HIV/AIDS programs and HCV screening, care and treatment.
H.R. 2346, S. 1054 FY09 Supplemental Appropriations related to preparedness for pandemic influenza.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Legislation on public health preparedness and response related to pandemic influenza. S.1445 and H.R. 2552, Senate and House versions of the Hepatitis C Epidemic Control and Prevention Act.
Influenza Pandemic Preparedness federal, state and local levels.
H.R. 3200, health care reform legislationRyan White CARE Act reauthorization
Agencies Lobbied
U.S. House of Representatives
2nd Quarter, 2009
In Q2, WINNING STRATEGIES WASHINGTON lobbied for HOFFMAN-LA ROCHE, INC , earning $80,000. The report was filed on July 20, 2009.
Original Filing: 300189333.xml
Lobbying Issues
FY10 Labor, HHS and Education Appropriation related to preparedness for pandemic influenza, HIV/AIDS programs and HCV screening, care and treatment.
H.R. 2346, S. 1054 FY09 Supplemental Appropriations related to preparedness for pandemic influenza.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Legislation on public health preparedness and response related to pandemic influenza. S.1445 and H.R. 2552, Senate and House versions of the Hepatitis C Epidemic Control and Prevention Act.
Influenza Pandemic Preparedness federal, state and local levels.
Agencies Lobbied
U.S. House of Representatives
1st Quarter, 2009
In Q1, WINNING STRATEGIES WASHINGTON lobbied for HOFFMAN-LA ROCHE, INC , earning $80,000. The report was filed on April 20, 2009.
Original Filing: 300158868.xml
Lobbying Issues
S. 3230 FY09 Labor, HHS and Education Appropriation related to preparedness for pandemic influenza, HIV/AIDS programs and HCV screening, care and treatment.
S. 3181 FY09 Homeland Security Appropriations and H.R. 2638 Continuing Resolution related to preparedness for pandemic influenza.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Legislation on public health preparedness and response related to pandemic influenza. S.1445 and H.R. 2552, Senate and House versions of the Hepatitis C Epidemic Control and Prevention Act.
Influenza Pandemic Preparedness federal, state and local levels.
Agencies Lobbied
U.S. House of Representatives
4th Quarter, 2008
In Q4, WINNING STRATEGIES WASHINGTON lobbied for HOFFMAN-LA ROCHE, INC , earning $20,000. The report was filed on Jan. 16, 2009.
Original Filing: 300123578.xml
Lobbying Issues
S. 3230 FY09 Labor, HHS and Education Appropriation related to preparedness for pandemic influenza, HIV/AIDS programs and HCV screening, care and treatment.
S. 3181 FY09 Homeland Security Appropriations and H.R. 2638 Continuing Resolution related to preparedness for pandemic influenza.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Legislation on public health preparedness and response related to pandemic influenza. S.1445 and H.R. 2552, Senate and House versions of the Hepatitis C Epidemic Control and Prevention Act.
Influenza Pandemic Preparedness federal, state and local levels.
Agencies Lobbied
U.S. House of Representatives
3rd Quarter, 2008
In Q3, WINNING STRATEGIES WASHINGTON lobbied for HOFFMAN-LA ROCHE, INC , earning $60,000. The report was filed on Oct. 17, 2008.
Original Filing: 300097956.xml
Lobbying Issues
S. 3230 FY09 Labor, HHS and Education Appropriation related to preparedness for pandemic influenza, HIV/AIDS programs and HCV screening, care and treatment.
S. 3181 FY09 Homeland Security Appropriations and H.R. 2638 Continuing Resolution related to preparedness for pandemic influenza.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Legislation on public health preparedness and response related to pandemic influenza. S.1445 and H.R. 2552, Senate and House versions of the Hepatitis C Epidemic Control and Prevention Act.
Influenza Pandemic Preparedness federal, state and local levels.
Agencies Lobbied
U.S. House of Representatives
2nd Quarter, 2008
In Q2, WINNING STRATEGIES WASHINGTON lobbied for HOFFMAN-LA ROCHE, INC , earning $60,000. The report was filed on July 18, 2008.
Original Filing: 300074507.xml
Lobbying Issues
FY09 Labor, HHS and Education Appropriation related to preparedness for pandemic influenza, HIV/AIDS programs and HCV screening, care and treatment.
S. 3181 FY09 Homeland Security Appropriations related to preparedness for pandemic influenza.
FY08 Emergency Supplemental Appropriations related to preparedness for pandemic influenza
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Legislation on public health preparedness and response related to pandemic influenza. S.1445 and H.R. 2552, Senate and House versions of the Hepatitis C Epidemic Control and Prevention Act.
Influenza Pandemic Preparedness federal, state and local levels.
Agencies Lobbied
U.S. House of Representatives
1st Quarter, 2008
In Q1, WINNING STRATEGIES WASHINGTON lobbied for HOFFMAN-LA ROCHE, INC , earning $80,000. The report was filed on April 18, 2008.
Original Filing: 300043935.xml
Lobbying Issues
FY09 Labor, HHS and Education Appropriation related to preparedness for pandemic influenza, HIV/AIDS programs and HCV screening, care and treatment.
FY09 Homeland Security Appropriations related to preparedness for pandemic influenza.
FY08 Emergency Supplemental Appropriations related to preparedness for pandemic influenza
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Early Early Treatment for HIV Act.
Legislation on public health preparedness and response related to pandemic influenza. S.1445 and H.R. 2552, Senate and House versions of the Hepatitis C Epidemic Control and Prevention Act.
Influenza Pandemic Preparedness federal, state and local levels
Agencies Lobbied
U.S. House of Representatives
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate
Searching...